Evonik Expanding MMAT Plant in Alabama by 2015

Germany's Evonik has begun expanding is MMA transesterification (MMAT) plant at Mobile, Alabama, in response to what it said is increasing demand.

Without disclosing an investment value, the group said the project will cost in the "multi-million-dollar range." It also did not disclose capacity, saying only that its capacity would "rise significantly" at start-up in late 2014.

The expansion reflects the strength of the markets supplied by the MMAT plant and a continued confidence in the ability of Evonik's Mobile site to deliver impressive results to its performance polymers business, the group's North American subsidiary said.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.